Abstract
Small non-cleaved cell lymphoma is one of the most rapidly growing malignancies and in children is highly curable. However, in adults, the disease is disseminated in approximately one half of the patients, and with standard chemotherapy used for lymphoma, is less curable than it is in children, especially in patients presenting with bone marrow involvement. However, recent developments in clinical management using intensive dose therapy for this disease have improved the eventual outcome for these patients. This review focuses on some of these improvements.
Original language | English (US) |
---|---|
Pages (from-to) | 433-441 |
Number of pages | 9 |
Journal | Biomedicine and Pharmacotherapy |
Volume | 50 |
Issue number | 9 |
DOIs | |
State | Published - 1996 |
Keywords
- Bone marrow transplant
- Burkitt's lymphoma
- Chemotherapy
- Small non-cleaved cell lymphomas
ASJC Scopus subject areas
- Pharmacology